Literature DB >> 33313936

Repetitive Daylight Photodynamic Therapy versus Cryosurgery for Prevention of Actinic Keratoses in Photodamaged Facial Skin: A Prospective, Randomized Controlled Multicentre Two-armed Study.

Sigrid Karrer1, Rolf-Markus Szeimies, Wolfgang G Philipp-Dormston, Peter A Gerber, Welf Prager, Elisabeth Datz, Florian Zeman, Karolina Müller, Michael Koller.   

Abstract

Actinic keratoses are a chronic condition in ultraviolet-damaged skin, with a risk of progressing to invasive skin cancer. The aim of this study was to investigate the preventive potential of field-directed repetitive daylight photodynamic therapy for actinic keratoses. A randomized trial was performed, including 58 patients with ≥5 actinic keratoses on photodamaged facial skin, who received either 5 full-face sessions of daylight photodynamic therapy within a period of 2 years or lesion-directed cryosurgery. Primary outcome was the mean cumulative number of new actinic keratoses developed between visits 2 and 6 (visit 6 being a follow-up). This outcome was lower after daylight photo-dynamic therapy (7.7) compared with cryosurgery (10.2), but the difference did not reach significance (-2.5, 95% confidence interval -6.2 to 1.2; p=0.18). Several signs of photoageing (fine lines, pigmentation, roughness, erythema, sebaceous gland hyperplasia) were significantly reduced after daylight photodynamic therapy, but not after cryosurgery. Significantly less pain and fewer side-effects were reported during daylight photodynamic therapy than during cryosurgery. This study found that repetitive daylight photodynamic therapy had photo-rejuvenating effects. However, the prevention of actinic keratoses by this therapy could not be proven in a statistically reliable manner.

Entities:  

Keywords:  daylight photodynamic therapy; methyl aminolevulinate; photo-rejuvenation; skin ageing; skin cancer prevention; actinic keratoses

Mesh:

Substances:

Year:  2021        PMID: 33313936      PMCID: PMC9309835          DOI: 10.2340/00015555-3717

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  30 in total

1.  Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.

Authors:  C Morton; S Campbell; G Gupta; S Keohane; J Lear; I Zaki; S Walton; N Kerrouche; G Thomas; P Soto
Journal:  Br J Dermatol       Date:  2006-11       Impact factor: 9.302

Review 2.  The importance of treating the field in actinic keratosis.

Authors:  E Stockfleth
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-03       Impact factor: 6.166

3.  Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers.

Authors:  L Bagazgoitia; J Cuevas Santos; A Juarranz; P Jaén
Journal:  Br J Dermatol       Date:  2011-05-26       Impact factor: 9.302

4.  S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators.

Authors:  Markus V Heppt; Ulrike Leiter; Theresa Steeb; Teresa Amaral; Andrea Bauer; Jürgen C Becker; Eckhard Breitbart; Helmut Breuninger; Thomas Diepgen; Thomas Dirschka; Thomas Eigentler; Michael Flaig; Markus Follmann; Klaus Fritz; Rüdiger Greinert; Ralf Gutzmer; Uwe Hillen; Stephan Ihrler; Swen Malte John; Oliver Kölbl; Klaus Kraywinkel; Christoph Löser; Dorothée Nashan; Seema Noor; Monika Nothacker; Christina Pfannenberg; Carmen Salavastru; Lutz Schmitz; Eggert Stockfleth; Rolf-Markus Szeimies; Claas Ulrich; Julia Welzel; Kai Wermker; Carola Berking; Claus Garbe
Journal:  J Dtsch Dermatol Ges       Date:  2020-03       Impact factor: 5.584

5.  Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.

Authors:  S Karrer; R A G Aschoff; R Dominicus; G Krähn-Senftleben; G G Gauglitz; A Zarzour; N Kerrouche; R Chavda; R-M Szeimies
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-02-22       Impact factor: 6.166

6.  Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin.

Authors:  Cristina Zane; Rossana Capezzera; Raffaella Sala; Marina Venturini; Piergiacomo Calzavara-Pinton
Journal:  Lasers Surg Med       Date:  2007-03       Impact factor: 4.025

7.  Primary prevention of skin dysplasia in renal transplant recipients with photodynamic therapy: a randomized controlled trial.

Authors:  K Togsverd-Bo; S H Omland; H C Wulf; S S Sørensen; M Haedersdal
Journal:  Am J Transplant       Date:  2015-05-27       Impact factor: 8.086

8.  Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients.

Authors:  Hans Christian Wulf; Stan Pavel; Ida Stender; Christianne Ahb Bakker-Wensveen
Journal:  Acta Derm Venereol       Date:  2006       Impact factor: 4.437

9.  Photorejuvenation with topical methyl aminolevulinate and red light: a randomized, prospective, clinical, histopathologic, and morphometric study.

Authors:  Maria Cláudia Almeida Issa; Juan Piñeiro-Maceira; Maria Teresa Campos Vieira; Beni Olej; Carlos A Mandarim-de-Lacerda; Ronir Raggio Luiz; Mônica Manela-Azulay
Journal:  Dermatol Surg       Date:  2009-12-04       Impact factor: 3.398

10.  Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy.

Authors:  Andrea Willey; Sheetal Mehta; Peter K Lee
Journal:  Dermatol Surg       Date:  2009-11-04       Impact factor: 3.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.